Patterns of use of P2Y12 inhibitors in patients with acute coronary syndrome in routine clinical practice

被引：0
|
作者：
Yuan, Zhong [1 ]
Hardin, Jill [1 ]
Voss, Erica A. [2 ]
Hester, Laura L. [1 ]
Weaver, James [1 ]
Davis, Kourtney [1 ]
Barnathan, Elliot S. [2 ]
机构：
[1] Janssen Res & Dev LLC, Titusville, NJ USA
[2] Janssen Res & Dev LLC, Raritan, NJ USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2019年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
288
引用
收藏
页码：143 / 143
页数：1
相关论文
共 50 条
  • [1] P2Y12 inhibitors in acute coronary syndrome: relation to hemorrhagic events in routine clinical practice
    Godinho, A. R.
    Viana, M.
    Correia, S.
    Dias, P.
    Almeida, R.
    Aszczynska, O.
    Araujo, C.
    Moreira, I.
    Maciel, M. J.
    Azevedo, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 108 - 108
  • [2] P2Y12 Inhibitor Adherence Patterns in Patients with Acute Coronary Syndrome
    Ozaki, Aya
    Ko, Dennis T.
    Chong, Alice
    Fang, Jiming
    Austin, Peter
    Sud, Maneesh
    Jackevicius, Cynthia A.
    CIRCULATION, 2021, 144
  • [3] Potent P2Y12 receptor inhibitors in patients with acute coronary syndrome Agents, indications, issues to consider in clinical practice
    Sibbing, D.
    Orban, M.
    Massberg, S.
    HAMOSTASEOLOGIE, 2013, 33 (01): : 9 - 15
  • [4] Comparison of Oral P2Y12 Inhibitors in Acute Coronary Syndrome
    Ferracane, Elisa
    Bartoli, Laura
    Trippoli, Sabrina
    Messori, Andrea
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 135 : 183 - 184
  • [5] Choice of P2Y12 Inhibitors After Acute Coronary Syndrome
    Ando, Giuseppe
    Gragnano, Felice
    Pelliccia, Francesco
    Calabro, Paolo
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 211 : 377 - 377
  • [6] Characteristics of new P2Y12 inhibitors: selection of P2Y12 inhibitors in clinical practice
    Golino, Paolo
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2013, 14 : S22 - S30
  • [7] Combined Use of Warfarin and Oral P2Y12 Inhibitors in Patients With Atrial Fibrillation and Acute Coronary Syndrome
    Jones, William S.
    Mi, Xiaojuan
    Patel, Manesh R.
    Mills, Rogers
    Hernandez, Adrian F.
    Curtis, Lesley H.
    CIRCULATION, 2013, 128 (22)
  • [8] Combined Use of Warfarin and Oral P2Y12 Inhibitors in Patients With Atrial Fibrillation and Acute Coronary Syndrome
    Jones, W. Schuyler
    Mi, Xiaojuan
    Patel, Manesh R.
    Mills, Roger
    Hernandez, Adrian F.
    Curtis, Lesley H.
    CLINICAL CARDIOLOGY, 2014, 37 (03) : 152 - 159
  • [9] Should P2Y12 inhibitors be given for 12 months in acute coronary syndrome?
    Christodoulidis, Georgios
    Baber, Usman
    Mehran, Roxana
    CURRENT OPINION IN CARDIOLOGY, 2014, 29 (04) : 301 - 306
  • [10] Clinical implications of diabetes mellitus in patients with acute coronary syndrome: Prognostic role and use of new P2Y12 receptor inhibitors
    Gil-Perez, Pablo
    Miguel Ruiz-Nodar, Juan
    Asuncion Esteve-Pastor, Maria
    Hortelano, Ignacio
    Villamia, Beatriz
    Vicente-Ibarra, Nuria
    Orenes-Pinero, Esteban
    Jesus Macias, Manuel
    Nunez-Martinez, Laura
    Carrillo, Luna
    Candela, Elena
    Veliz-Martinez, Andrea
    Lopez-Garcia, Cecilia
    Gabriel Martinez-Martinez, Juan
    Miguel Rivera-Caravaca, Jose
    Marin, Francisco
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 184
12345